Detalhe da pesquisa
1.
Cytoskeletal protein degradation in brain death donor kidneys associates with adverse posttransplant outcomes.
Am J Transplant
; 22(4): 1073-1087, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34878723
2.
TRPC6 Binds to and Activates Calpain, Independent of Its Channel Activity, and Regulates Podocyte Cytoskeleton, Cell Adhesion, and Motility.
J Am Soc Nephrol
; 30(10): 1910-1924, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31416818
3.
Mapping the binding site of the P2X receptor antagonist PPADS reveals the importance of orthosteric site charge and the cysteine-rich head region.
J Biol Chem
; 293(33): 12820-12831, 2018 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29997254
4.
Use of chimeras, point mutants, and molecular modeling to map the antagonist-binding site of 4,4',4â³,4â´-(carbonylbis-(imino-5,1,3-benzenetriylbis(carbonylimino)))tetrakisbenzene-1,3-disulfonic acid (NF449) at P2X1 receptors for ATP.
J Biol Chem
; 290(3): 1559-69, 2015 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-25425641
5.
P2X receptor chimeras highlight roles of the amino terminus to partial agonist efficacy, the carboxyl terminus to recovery from desensitization, and independent regulation of channel transitions.
J Biol Chem
; 288(29): 21412-21421, 2013 Jul 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-23740251
6.
Shiga toxin targets the podocyte causing hemolytic uremic syndrome through endothelial complement activation.
Med
; 4(11): 761-777.e8, 2023 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37863058
7.
VEGFC Reduces Glomerular Albumin Permeability and Protects Against Alterations in VEGF Receptor Expression in Diabetic Nephropathy.
Diabetes
; 68(1): 172-187, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30389746